192 related articles for article (PubMed ID: 19223666)
21. Role of endogenous hydrogen peroxide in the development of nitrate tolerance.
Ghatta S; Hemmer RB; Uppala S; O'Rourke ST
Vascul Pharmacol; 2007 Apr; 46(4):247-52. PubMed ID: 17157562
[TBL] [Abstract][Full Text] [Related]
22. Mechanism of ITF 296-induced vasorelaxation compared to nitroglycerin and isosorbide dinitrate: relationship between relaxation of rabbit aorta and tissue cGMP.
Donà G; Giuliani P; Cremonesi P; Passaro A; Stella P; Tursi F; Mizrahi J
J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S59-66. PubMed ID: 8839228
[TBL] [Abstract][Full Text] [Related]
23. Vitamin E deficiency accelerates nitrate tolerance via a decrease in cardiac P450 expression and increased oxidative stress.
Minamiyama Y; Takemura S; Hai S; Suehiro S; Okada S
Free Radic Biol Med; 2006 Mar; 40(5):808-16. PubMed ID: 16520233
[TBL] [Abstract][Full Text] [Related]
24. Reduction potentials of protein disulfides and catalysis of glutathionylation and deglutathionylation by glutaredoxin enzymes.
Ukuwela AA; Bush AI; Wedd AG; Xiao Z
Biochem J; 2017 Nov; 474(22):3799-3815. PubMed ID: 28963348
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and rebound phenomenon related to intermittent nitroglycerin therapy for the prevention of nitrate tolerance.
Watanabe H; Kakihana M; Ohtsuka S; Sugishita Y
Jpn Circ J; 1998 Aug; 62(8):571-5. PubMed ID: 9741733
[TBL] [Abstract][Full Text] [Related]
26. Nitroglycerin-induced relaxation of anorectal smooth muscle: evidence for apparent lack of tolerance development in the anaesthetized rat.
Wang EQ; Soda DM; Fung HL
Br J Pharmacol; 2001 Sep; 134(2):418-24. PubMed ID: 11564661
[TBL] [Abstract][Full Text] [Related]
27. Vascular peroxynitrite formation during organic nitrate tolerance.
Mihm MJ; Coyle CM; Jing L; Bauer JA
J Pharmacol Exp Ther; 1999 Oct; 291(1):194-8. PubMed ID: 10490904
[TBL] [Abstract][Full Text] [Related]
28. Prevention of nitrate tolerance by long-term treatment with statins.
Fontaine D; Otto A; Fontaine J; Berkenboom G
Cardiovasc Drugs Ther; 2003 Mar; 17(2):123-8. PubMed ID: 12975593
[TBL] [Abstract][Full Text] [Related]
29. The nitric oxide donor SIN-1 is free of tolerance and maintains its cyclic GMP stimulatory potency in nitrate-tolerant LLC-PK1 cells.
Hinz B; Schröder H
Pharm Res; 1999 May; 16(5):633-6. PubMed ID: 10350003
[TBL] [Abstract][Full Text] [Related]
30. S-glutathionylation impairs signal transducer and activator of transcription 3 activation and signaling.
Xie Y; Kole S; Precht P; Pazin MJ; Bernier M
Endocrinology; 2009 Mar; 150(3):1122-31. PubMed ID: 18988672
[TBL] [Abstract][Full Text] [Related]
31. Recovery of vascular smooth muscle relaxation from nitroglycerin-induced tolerance following a drug-free interval. A time-course in vitro study.
Mehta JL; Lawson DL; Nichols WW
Biochem Pharmacol; 1991 Mar; 41(5):743-7. PubMed ID: 1847812
[TBL] [Abstract][Full Text] [Related]
32. Sustained antiplatelet properties of nitroglycerin during hemodynamic tolerance in rats.
Booth BP; Jacob S; Bauer JA; Fung HL
J Cardiovasc Pharmacol; 1996 Sep; 28(3):432-8. PubMed ID: 8877591
[TBL] [Abstract][Full Text] [Related]
33. Nitroglycerin fails to lower blood pressure in redox-dead Cys42Ser PKG1α knock-in mouse.
Rudyk O; Prysyazhna O; Burgoyne JR; Eaton P
Circulation; 2012 Jul; 126(3):287-95. PubMed ID: 22685118
[TBL] [Abstract][Full Text] [Related]
34. Evidences for prevention of nitroglycerin tolerance by carvedilol.
El-Demerdash E
Pharmacol Res; 2006 Apr; 53(4):380-5. PubMed ID: 16503407
[TBL] [Abstract][Full Text] [Related]
35. Effects of the flavoprotein inhibitor, diphenyleneiodonium sulfate, on ex vivo organic nitrate tolerance in the rat.
Ratz JD; McGuire JJ; Anderson DJ; Bennett BM
J Pharmacol Exp Ther; 2000 May; 293(2):569-77. PubMed ID: 10773030
[TBL] [Abstract][Full Text] [Related]
36. No cross-tolerance between S-nitrosocaptopril and nitroglycerin in dog coronary arteries in vivo.
Takaoka A; Nakae I; Takahashi M; Matsumoto T; Liu Q; Mitsunami K; Kinoshita M
J Cardiovasc Pharmacol; 1998 Feb; 31(2):231-9. PubMed ID: 9475264
[TBL] [Abstract][Full Text] [Related]
37. Effects of long-term nitroglycerin treatment on endothelial nitric oxide synthase (NOS III) gene expression, NOS III-mediated superoxide production, and vascular NO bioavailability.
Münzel T; Li H; Mollnau H; Hink U; Matheis E; Hartmann M; Oelze M; Skatchkov M; Warnholtz A; Duncker L; Meinertz T; Förstermann U
Circ Res; 2000 Jan; 86(1):E7-E12. PubMed ID: 10625313
[TBL] [Abstract][Full Text] [Related]
38. Degradation of leucine zipper-positive isoform of MYPT1 may contribute to development of nitrate tolerance.
Dou D; Ma H; Zheng X; Ying L; Guo Y; Yu X; Gao Y
Cardiovasc Res; 2010 Apr; 86(1):151-9. PubMed ID: 19939965
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms of reversible protein glutathionylation in redox signaling and oxidative stress.
Gallogly MM; Mieyal JJ
Curr Opin Pharmacol; 2007 Aug; 7(4):381-91. PubMed ID: 17662654
[TBL] [Abstract][Full Text] [Related]
40. Clinical tolerance to nitroglycerin is due to impaired biotransformation of nitroglycerin and biological counterregulation, not to desensitization of guanylate cyclase.
Mülsch A; Busse R; Bassenge E
Z Kardiol; 1989; 78 Suppl 2():22-5; discussion 64-7. PubMed ID: 2573982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
